Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral…
- German government reserves domestic manufacturing capacity until 2029 to ensure rapid access to mRNA vaccines developed by CureVac and…
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased…
NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma…
Chiesi Group turnover of €2.42bn supported by strong international growth of 8.6%Growth across global markets, with U.S. up more than…
Imprivata will unlock further value for customers by unifying, integrating, and automating digital identity to enable autonomous identity systemsWALTHAM, Mass.,…
Marks the first-ever in vivo delivery of an experimental CRISPR gene editing medicine to a pediatric patient Company on track…
Expanding their health insurance offerings, Sidecar Health launches large group health insurance in OhioEL SEGUNDO, Calif., April 11, 2022 (GLOBE…
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic…
CHARLOTTE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that…